Role of granulocyte colony stimulating factor in the treatment of cirrhosis of liver: a systematic review.

Siddheesh RajpurohitBalaji MusunuriPooja Basthi MohanGanesh BhatShiran Shetty

Published in: The Journal of international medical research (2023)

GCSF significantly improves the survival rate and disease severity scores, and reduces the incidence of complications in patients with liver cirrhosis. The administration of GCSF is likely to be effective in patients awaiting liver transplantation.

Keyphrases

end stage renal disease
risk factors
ejection fraction
prognostic factors
peripheral blood
patient reported outcomes
combination therapy
patient reported